Also trades as: BIOPOR.CO (CPH) · $vol 0M
THOXF OTC
BioPorto A/S
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -48.3%
1Y: -48.3%
3Y: -58.6%
5Y: -62.8%
$0.15
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$40M
+10.9% ▲
5Y CAGR: +11.6%
Gross Profit
$28M
+13.9% ▲
5Y CAGR: +15.9%
Operating Income
-$86M
-13.8% ▼
Net Income
-$82M
-20.1% ▼
EPS (Diluted)
$-0.15
+11.8% ▲
EBITDA
-$83M
-17.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $24M | $29M | $31M | $36M | $40M |
| YoY Growth | +4.5% | +19.4% | +6.9% | +17.1% | +10.9% |
| Cost of Revenue | $9M | $10M | $11M | $12M | $12M |
| Gross Profit | $15M | $19M | $20M | $25M | $28M |
| Gross Margin | 62.0% | 65.7% | 65.2% | 67.7% | 69.5% |
| R&D Expenses | $30M | $35M | $25M | $34M | $50M |
| SG&A Expenses | $50M | $63M | $55M | $66M | $64M |
| Operating Expenses | $80M | $98M | $81M | $100M | $114M |
| Operating Income | -$65M | -$79M | -$61M | -$75M | -$86M |
| Operating Margin | -269.0% | -272.5% | -197.6% | -208.2% | -213.7% |
| Interest Expense | $912K | $1M | $571K | $453K | $770K |
| Income Before Tax | -$64M | -$82M | -$61M | -$74M | -$87M |
| Tax Expense | -$7M | -$6M | -$5M | -$6M | -$6M |
| Net Income | -$57M | -$76M | -$56M | -$68M | -$82M |
| Net Margin | -235.5% | -262.1% | -181.9% | -188.3% | -203.8% |
| EPS (Diluted) | $-0.21 | $-0.23 | $-0.16 | $-0.17 | $-0.15 |
| EBITDA | -$59M | -$76M | -$58M | -$71M | -$83M |
| Shares Outstanding | 267M | 319M | 358M | 406M | 538M |